<- Go Home
ProtoKinetix, Incorporated
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company’s AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
Market Cap
$3.0M
Volume
110.6K
Cash and Equivalents
$2.2K
EBITDA
-$319.6K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$0.03
52 Week Low
$0.01
Dividend
N/A
Price / Book Value
7.06
Price / Earnings
-0.85
Price / Tangible Book Value
-52.94
Enterprise Value
$3.0M
Enterprise Value / EBITDA
-9.24
Operating Income
-$370.0K
Return on Equity
85.20%
Return on Assets
-49.17
Cash and Short Term Investments
$2.2K
Debt
N/A
Equity
$414.8K
Revenue
N/A
Unlevered FCF
-$196.8K
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium